Aberrantly activated PI3K/AKT/mTOR signaling pathway is known to play a central role in aerobic glycolytic reprogramming, tumor growth, and survival (32), and a cross-talk between PI3K/AKT/mTOR signaling and O-GlcNAcylation has been observed in several cancers. This evidence concerns the gene AKT1 and cancer.